F
Fulgent Genetics, Inc.
FLGT · NASDAQ · Healthcare · 527M
Closing price
$21.74
+4.42% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
0.6×
Enterprise value / EBITDAEV/EBITDA
-13.7×
Free cash flow yieldFCF yield
-18.6%
Return on equityROE
-5.4%
Operating margin
-28.2%
Net debt / EBITDAbalance-sheet strength
0.9×
Interest coverage
-1214.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.